Coping with vaccine manufacturing delays.
Where this comes from
- Record sourced from PubMed, PMID 11127985.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
With production of influenza vaccine delayed this year, physicians must prioritize and vaccinate those at highest risk first. Antiviral drugs can reduce the duration of symptoms by 1 to 2 days but should not be the first-line strategy for prevention.